Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology

AB Benson, MI D'Angelica, DE Abbott… - Journal of the National …, 2021 - jnccn.org
The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging,
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …

Tips for preparing and practicing thermal ablation therapy of hepatocellular carcinoma

Y Minami, T Aoki, S Hagiwara, M Kudo - Cancers, 2023 - mdpi.com
Simple Summary Thermal ablation, including radiofrequency ablation (RFA) and microwave
ablation (MWA), for hepatocellular carcinomas (HCCs) is accepted as a curative treatment …

[HTML][HTML] Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics

RIR Macias, MJ Monte, MA Serrano… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
Aging involves progressive physiological and metabolic reprogramming to adapt to gradual
deterioration of organs and functions. This includes mechanisms of defense against pre …

Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma

J Zhong, Y Ke, W Gong, L Ma, X Ye, T Peng… - Annals of …, 2014 - journals.lww.com
Objective: The efficacy and safety of hepatic resection (HR) to treat patients with Barcelona
Clinic Liver Cancer (BCLC) stage B and C hepatocellular carcinoma (HCC) was …

[PDF][PDF] Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system

CY Hsu, YH Lee, CY Hsia, YH Huang, CW Su… - …, 2013 - Wiley Online Library
Performance status is included in the Barcelona Clinic Liver Cancer (BCLC) system for
hepatocellular carcinoma (HCC). Few studies specifically evaluated the role of performance …

Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study

A Vitale, RR Morales, G Zanus, F Farinati… - The lancet …, 2011 - thelancet.com
Background Allocation of deceased-donor livers to patients with chronic liver failure is
improved by prioritising patients by 5-year liver transplantation survival benefit. The …

Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas

HH Hung, YY Chiou, CY Hsia, CW Su, YH Chou… - Clinical …, 2011 - Elsevier
BACKGROUND & AIMS:: Differences in efficacy of radiofrequency ablation (RFA) and
surgical resection (SR) are not clear for patients with hepatocellular carcinoma (HCC) …

NCCN guidelines insights: older adult oncology, version 2.2016

N VanderWalde, R Jagsi, E Dotan… - Journal of the National …, 2016 - jnccn.org
Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with
good performance status are able to tolerate commonly used treatment modalities as well as …

Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma

R Golfieri, JI Bilbao, L Carpanese, R Cianni… - Journal of …, 2013 - Elsevier
Background & Aims The European Network on Radioembolization with Yttrium-90 resin
microspheres study group (ENRY) conducted a retrospective study to evaluate the outcomes …

[HTML][HTML] Treatment for hepatocellular carcinoma in elderly patients: a literature review

H Nishikawa, T Kimura, R Kita, Y Osaki - Journal of Cancer, 2013 - ncbi.nlm.nih.gov
An aging society means that the number of elderly patients with cancer is predicted to rise in
the future. Hepatocellular carcinoma (HCC) usually develops in patients with hepatitis B …